Search Results

Displaying Results 1826-1850 of 9059 "'AGE'"

Jun 29, 2026, 07:05 ET REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone

retina.1About Diabetic RetinopathyDiabetic retinopathy (DR) is the leading cause of vision loss in adults between 24 and 75 years of age worldwide.2 DR affects nearly 10 million people in the United States alone.3 The spectrum of DR severity ranges from non-proliferative

More news about: REGENXBIO Inc.


Jun 29, 2026, 06:59 ET Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy

primary glomerulonephritis worldwide. Japan reports the highest incidence rates globally, at 39 to 45 cases per million population per year, with peak age at diagnosis between 30 and 39 years. In Japan, adult-onset IgAN is reported to progress to end-stage renal disease (dialysis or transplantation) in

More news about: Viatris Inc.


Jun 29, 2026, 06:00 ET LORD ASHCROFT POLLS REVEALS STATE OF THE AMERICAN DREAM AT 250

optimistic for their own future, though fewer than half were optimistic for the US as a whole. Those aged 18-24 were less optimistic than older age groups, both for themselves and the country. African Americans were slightly more optimistic on both counts than white or Hispanic Americans.Lord

More news about: Lord Ashcroft


Jun 29, 2026, 03:18 ET Leading Chinese Robotics Company Sets Sights on Off-Screen AI Education

SHANGHAI, June 29, 2026 /PRNewswire/ -- What should children actually learn in the age of AI? That question has been shaping some of the recent work happening around WhalesBot's AI+Robotics Exploration Centers across China, where schools

More news about: WhalesBot


Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

malignancy or history of malignancy)Use in patients 65 years of age and olderConsidering the increased risk of MACE, malignancies, serious infections, and all-cause mortality in patients ≥65 years of age, as observed in a large randomised study of tofacitinib (another Janus Kinase

More news about: AbbVie


Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

malignancy or history of malignancy)Use in patients 65 years of age and olderConsidering the increased risk of MACE, malignancies, serious infections, and all-cause mortality in patients ≥65 years of age, as observed in a large randomised study of tofacitinib (another Janus Kinase

More news about: AbbVie


Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

malignancy or history of malignancy)Use in patients 65 years of age and olderConsidering the increased risk of MACE, malignancies, serious infections, and all-cause mortality in patients ≥65 years of age, as observed in a large randomised study of tofacitinib (another Janus Kinase

More news about: AbbVie


Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

malignancy or history of malignancy)Use in patients 65 years of age and olderConsidering the increased risk of MACE, malignancies, serious infections, and all-cause mortality in patients ≥65 years of age, as observed in a large randomised study of tofacitinib (another Janus Kinase

More news about: AbbVie


Jun 28, 2026, 20:05 ET A 'founding father of fitness' - Les Mills Snr 1934 - 2026

partner Jackie, now supported by their children Diana and Les Jnr.Born in Auckland in 1934, Les had a tough start in life, losing his father at age 11, but he found solace in his passion for fitness and physical culture, inspired by the Charles Atlas strength training program. He grew into a fearsome

More news about: Les Mills


Jun 28, 2026, 19:32 ET A 'founding father of fitness' - Les Mills Snr 1934 - 2026

partner Jackie, now supported by their children Diana and Les Jnr.Born in Auckland in 1934, Les had a tough start in life, losing his father at age 11, but he found solace in his passion for fitness and physical culture, inspired by the Charles Atlas strength training program. He grew into a fearsome

More news about: Les Mills


Jun 26, 2026, 18:01 ET EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

researchers believe the findings may be explained by differences in cognitive reserve – the brain's ability to continue functioning effectively despite age-related changes or damage caused by disease.Lead author Dr Carolina Ferreira-Atuesta explained: "Most people with hearing loss have enough cognitive

More news about: EAN Congress


Jun 26, 2026, 18:01 ET EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

researchers believe the findings may be explained by differences in cognitive reserve – the brain's ability to continue functioning effectively despite age-related changes or damage caused by disease.Lead author Dr Carolina Ferreira-Atuesta explained: "Most people with hearing loss have enough cognitive

More news about: EAN Congress


Jun 26, 2026, 17:01 ET Storm hardening, electric grid upgrades and new generation underpin request to update electric rates in mid-2027

Keeping Cool program provides summer bill credits for eligible seniors, the disabled, and families with medical challenges or children under age 5. The

More news about: Ameren Missouri


Jun 26, 2026, 16:50 ET SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

psoriasis in adults and children 6 years of age and older who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).active psoriatic arthritis in adults and children 6 years of age and older.moderate to severe Crohn's

More news about: AbbVie


Jun 26, 2026, 16:33 ET Alliance for a Better Future releases analysis of KIDS Act

process provided no time to address the issues. This bill lacks a real duty of care, age verification, robust chatbot safeguards, and true respect for kids' privacy. Parents must have control of their children's data until age 18. And Congress must fix the legal ambiguities that may preempt common law, blocking

More news about: Alliance for a Better Future


Jun 26, 2026, 15:50 ET WNC & ASSOCIATES CELEBRATES GRAND OPENING OF CLIFFMORE PARK, A 72-UNIT AFFORDABLE SENIOR HOUSING COMMUNITY IN FAYETTEVILLE

million in equity to support the development."Cliffmore Park reflects the power of thoughtful partnerships to create housing that allows seniors to age with dignity, independence, and stability," said Ryan Thayer, assistant vice president of originations at WNC. "We are grateful to Resource Housing Group,

More news about: WNC & Associates, Inc.


Jun 26, 2026, 13:16 ET The Inner Circle acknowledges Dr. Barbara Betancourt Cortes as a Pinnacle Lifetime Member

open water swimming and water polo. She also competed on the University of Puerto Rico swim team and excelled in long-distance swimming events from the age of seven through her early twenties. In addition, she was recognized as the first runner-up in the Miss World Puerto Rico competition.Dr. Cortes

More news about: The Inner Circle


Jun 26, 2026, 12:35 ET Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

HERE.IMAAVY is approved for adult and pediatric patients (12 years of age and older) with anti-AChR or anti-MuSK antibody positive gMG by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).10,11Editor's

More news about: Johnson & Johnson


Jun 26, 2026, 10:30 ET Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted

complications. Major risk factors include hypertension, hyperlipidemia, hyperglycemia, smoking, excessive drinking, sedentary lifestyle, obesity and advanced age. Mostly developing chronically with acute episodes, they rank as the top chronic diseases threatening the health of middle-aged and elderly people.Cardiovascular

More news about: Jiangsu Vcare Pharmatech Co., Ltd.


Jun 26, 2026, 10:23 ET Group 1 Automotive Announces Toyota Certified at Capital Plaza is now Group 1 Toyota Certified Capital Plaza

rates and terms, many lenders work with a range of credit profiles. Approval may also depend on income, debt-to-income ratio, down payment, and the age and mileage of the vehicle being financed.What are the benefits of a certified pre-owned Toyota?Certified pre-owned Toyota vehicles

More news about: Group 1 Automotive, Inc.


Jun 26, 2026, 10:17 ET Group 1 Automotive Announces the Toyota Certified at Capital Plaza Collision Center is now Group 1 Toyota Capital Plaza Collision

factory specifications, while aftermarket parts are made by third-party companies. The parts used in a repair may depend on insurance coverage, vehicle age, availability, and customer preference.How long do collision repairs typically take?Repair timelines depend on the extent of the

More news about: Group 1 Automotive, Inc.


Jun 26, 2026, 09:40 ET Largest Nurse and Healthcare Professional Strike in Massachusetts History Scheduled for July 8 as 4,500 MNA Nurses and Clinicians Plan Walk Out at Brigham and Women's Hospital and MGB Home Care

Economic data showing that from 2020 to 2024, the income needed to maintain a middle-class standard of living for a two-parent family with two school-age children in Massachusetts jumped nearly 50 percent, according to 

More news about: Massachusetts Nurses Association


Jun 26, 2026, 09:05 ET Servier Presentations at ISPNO 2026 Highlight Neuro-Oncology Leadership and Expanding Glioma Portfolio

RAF kinase inhibitor of mutant BRAF V600, wild-type BRAF, and wild-type CRAF kinases. OJEMDA is indicated for the treatment of patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. This indication

More news about: Servier Pharmaceuticals


Jun 26, 2026, 09:01 ET Students Help Educate on the Dangers of Distracted Driving Through the 2026 Project Yellow Light Competition

Project Yellow Light was created in 2007 in memory of Hunter Garner, who lost his life in a car crash at the age of 16.

More news about: The Ad Council


Jun 26, 2026, 09:00 ET Children's Lighthouse Builds Mid-Year Momentum With Strategic Growth, Technology Innovation and New School Development

Pathways® curriculum, which combines age-appropriate education with character development and values-based learning. The curriculum includes Lighthouse BRIGHT® for infants and toddlers, Lighthouse CARES® for preschool-aged children and xSTREAM Quest® for school-age students, helping children develop academic,

More news about: Children's Lighthouse


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.